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 ABSTRACT 
 
Background And Objective:  
T h e  commonest disease that disturbs the day to day activity of 
thousands of individuals was recognised as chronic rhinosinusitis .The 
purpose of the research was to analyse the degree of improvement of 
symptom profile in patients suffering from chronic sinusitis undergoing  
endoscopic sinus surgery  and to explain about the success or limitation 
of the procedure depending upon the extent to which patient experiences 
improvement in individual symptoms. 
 
Study design:  
Prospective Study 
 
Methods:  
A group of 60 individuals with symptom of chronic sinusitis 
were considered in the study. They underwent FESS at the department 
of oto-rhino-laryngology, Govt.Kilpauk Medical College Hospital and 
Govt. Royapettah Hospital. Patients were assessed for the CRS related 
and unrelated symptoms preoperatively using SNOT-22system and scores 
were as no symptom(0),very mild (1), mild (2), moderate (3) severe (4), 
problem as bad as it can be(5).Three times scoring, one before surgery 
and two after surgery done. Statistical analysis were done  using  Chi 
square test. 
 
 Results:  
The symptoms that showed the marked improvement in majority of 
the subjects were nasal obstruction (88.3%),nasal discharge(78.3%),post 
nasal dripping (68.3%),ear discharge(70%),decreased sensation of smell 
(68.3%) and which showed no or mild improvement were ,headache, 
cough, rhinnorrhoea, sneezing, facial pain, those symptoms associated 
with allergic rhinitis.  
Conclusion: 
The symptoms that showed the marked improvement in majority of 
the subjects were nasal obstruction, nasal discharge, post nasal dripping, 
ear discharge, headache and which showed no or mild improvement is 
cough, rhinnorrhoea, sneezing, facial pain those symptoms associated 
with allergic rhinitis. And the non specific symptoms such as fatigue and 
bodily pain are largely dependant on the symptoms which show not much 
improvement. So they too showed poor improvement in parallel to those 
poorly improved symptoms. In few proportion  where these symptoms 
showed a moderate improvement the patients said they experienced 
marked improvement of these non specific symptoms like fatigue and 
bodily pain. If patients who come to the out patient department and 
diagnosed to have chronic rhinosinusitis  and have their predominant 
symptoms like  in this study which showed no or only poor improvement 
then it is not to intervene  them  with endoscopic sinus surgery. And its 
better to give them a course of anti allergic measures.   
Key words: 
Chronic rhinosinusitis; Nasal obstruction; Treatment outcome. 
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INTRODUCTION 
Many disease processes including Chronic Rhino Sinusitis (CRS)  
Clinical diagnostic measures are not able to identify  the full burden of 
the disease. The  discordance between Radiological / Pre op endoscopic 
findings and Patient symptoms highlights this dilemma. Degree of 
sinonasal inflammation as measured by CT/DNE (diagnostic nasal 
endoscopy) fails to correlate with the extent of symptoms experienced by 
the patient. At present Chronic Rhino Sinusitis (CRS) remains a symptom 
based diagnosis corroborated by objective signs. A lack of agreement 
between objective assessment and patient centered assessment is seen in 
CRS, obstructive sleep apnoea, asthma and low back pain. Its important 
to assess the minimally clinically important difference (MCID), defined 
as the minimal change in symptom after a given intervention that is 
perceptible / relevant to the concerned individual. 
The extent of symptoms experienced by the patient remains the 
overriding factor in seeking medical or surgical treatment. Study of 
patient centered disease impact is critical in understanding quality of life 
outcomes after FESS. Many studies such as Rhinosinusitis Disability 
index(RSDI),Chronic Sinusitis Survey (CSS), Rhinitis QOL 
questionnaire, 22 stem  Sino Nasal Outcome Test (SNOT-22) provide 
validated means to objectively quantify patients perception of disease 
burden in terms of symptoms before and after instrumentation. 
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Therefore its important to analyse in order of priority the 
symptoms experienced by the patients suffering from chronic rhino 
sinusitis / sinonasal polyposis ,undergoing FESS, and to assess the 
outcome, taking into consideration few comorbid factors, which explains 
the success/limitation of the procedure and thus its impact in ultimately 
determining the Quality of Life outcome (QOL) after FESS. 
In the early twentieth century, Mosher said that intranasal 
ethmoidectomy is one of the most dangerous and blindest of all 
surgeries. This view changed dramatically with the advent of the 
endoscopes. Throughout the history of medicine numerous attempts 
have been made to illuminate and examine the inside of the various 
hallow cavities located within the body. 
In 1907, Hirschmann used a modified cystoscope to examine the 
middle meatus and study sinus ostia. The most significant development 
in nasal endoscopy was noticed during 1950’s when Hopkins 
developed solid rod lens with proximal cold light source. In the latter 
part of twentieth century sinonasal endoscopy has been established as an 
important component in our diagnostic and therapeutic armamentarium. 
The pioneering work of Prof Walter Messerklinger of Graz, 
Austria on sinus mucosa and mucociliary transport has brought light into 
the understanding the pathophysiology of sinus diseases. This can be 
summarized as below: 
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1. Most PNS infections spread from nose to sinus. 
2. Recurrent sinusitis is secondary to insufficient outflow or ostial 
obstruction 
3. Sites of obstruction or partial stenosis are the ethmoid 
infundibulum at the entrance to the maxillary and frontal sinus3,4. 
This work of Messerklinger has been appreciated and accepted. 
The earlier concept that frontal and maxillary sinuses are the culprits for 
chronicity of the disease is no longer accepted. This point was again 
confirmed by the introduction of CT-scan. 
Two Basic approaches namely the Messerklinger (1985) which is 
from anterior to posterior and Wigand approach (1978) which is from 
posterior to anterior approach done. Principles of both of these are once 
drainage is established, mucosa reverts from its temporary damage. 
FESS has gained popularity and continues to do so among the ENT 
surgeons in the recent years with the better understanding of the lateral 
wall of the nose. 
The present study is an attempt to assess the effect of FESS on the 
symptoms of patients with chronic sinonasal inflammatory disease before 
and after surgery. 
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Chronic rhinosinusitis is one of the most frequent 
otolaryngologic diseases encountered in routine ENT practice.  Chronic 
rhinosinusitis significantly impacts the quality of life by interfering 
with the general health, vitality and social functioning and cause 
decrease in productivity in the work force, which is comparable with 
that observed in patients with coronary heart disease and chronic lung 
disease. Chronic rhinosinusitis is one of the commonest conditions for 
which antibiotics are prescribed. Most cases of chronic rhinosinusitis 
respond to medical treatment but  if  no  improvement  in  symptoms  is  
achieved,  FESS  advocates  systematic approach to the surgical treatment 
of the disease of the nose and sinuses6,7. 
A BRIEF NOTE ABOUT SINO NASAL OUTCOME TEST 
SCORING (SNOT-22) 
1. Developed in the year 2003 in Danish language 
2. It encomprises the major symptoms as well as minor symptoms of 
chronic rhinosinusitis. 
3. There are about 22 items and asked in form of questionnaire. 
4. The scale ranges from 0-no problem to 5-problem as bad as it can 
be 
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5. It has been shown to have a good reliability, validity and 
responsiveness among patients and it takes around 7 mins to 
complete the questionnaire 
IMPORTANCE OF SNOT-22:- 
The Royal college of surgeons of England used the SNOT-22 
scoring for National comparative audit of surgery for chronic 
rhinosinusitis ,the questionnaire was simple and had a better discrimnant 
value and finally in 2009 it was validated and SNOT 22 came for  routine 
clinical practise. 
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AIM OF THE STUDY 
1. To assess the various symptoms of CRS before FESS. 
2. To compare the various symptoms of CRS before and after 
FESS. 
3. To assess the success or the limitation of  FESS depending on 
the degree of  improvement of individual symptoms which the 
patient experienced before and after  the procedure.  
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REVIEW OF LITERATURE 
According to Draf 1, Hirschmann performed the first attempts at 
nasal and sinus endoscopy in 1907 using a modified cystoscope. It 
was Maliz i n  New York who introduced the term sinoscopy and layed 
the methods for diagnosis of rhinosinusitis. In 1978, Messerklinger 
published the first systematic and detailed work documenting 
endoscopic findings in English. Messerklinger noted that wherever two 
opposing mucosa come into contact, the mucociliary transport mechanism 
is hampered , leading to stagnation and thus creating increased potential 
for infection even in the absence of ostial closure. The potential areas 
of mucosal contact lie in the middle meatus and the ethmoid air cell 
system. Messerklinger identified ventilatory defects in the middle meatus 
& anterior ethmoidal cells in patients with chronic and recurring sinus 
infections. These areas of persistent mucosal contact occurred either as 
a result of mucosal inflammation and hyperplasia following an infection, 
or as a result of an anatomic malformation. In majority of cases, 
infection spreads from the ethmoids to secondarily affect the maxillary 
and frontal sinuses. So the diseases of the frontal and the maxillary sinuses 
can be cured by clearance of the disease of the ethmoids8,9. 
Many years of endoscopic investigations and observations 
proved that most infections of PNS are rhinogenic, spreading from the 
nose into the sinuses. The common focus of infection in cases of 
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recurring sinusitis is the stenotic area of the anterior ethmoids with 
infection recurring in the larger sinuses. The anterior ethmoid, especially 
its infundibulum is the key location for infection, & cure of maxillary 
or frontal sinuses is fully dependent on the pathophysiologic condition 
there 3. 
FESS aims at the primary focus in the anterior ethmoids, 
clearing the stenotic clefts and infected ethmoid cells. The maxillary 
ostium is enlarged into nasal fontanellae to provide drainage and 
ventilation.  Once the ethmoidal focus is cleared, the dependent larger 
sinuses usually heal without having been touched even if their mucosal 
pathology seemed almost irreversible 4. 
The use of FESS has become popular with the improvement in 
understanding the lateral nasal wall skeletal framework and the surgical 
technique. Professor Messerklinger and Wigand introduced FESS in 
1960’s. It was popularized in Europe by Stammberger, and in North  
America  by  Kennedy. FESS has been accepted as a minimally invasive 
technique for treatment of CRS resistant to medical therapy. FESS 
restores sinus drainage, improves mucociliary clearance and reverts the 
sinus function to normal. 
Although much has been written about the surgical techniques of 
FESS, not much has appeared about its results. An analysis by Steven et 
al (1999) of 100 consecutive patients undergoing FESS over 23 
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months’ duration with average follow-up time of 5 months had average 
age of 39 yrs (range 6-83 yrs), 50 males and 50 females. 59 patients had 
recurrent sinusitis, 4 had polyps only, and 37 had both. 49 patients had 
previous sinus surgery. After FESS, 14 patients had minor 
complications, the most common complication being synechiae, between 
middle turbinate and septum in 6 patients. 83 patients had significant 
improvement after FESS while 10 had one episode of sinusitis 
postoperatively. The results of this series suggest that FESS is an 
efficacious advancement in treatment of sinusitis 10. In another study 
done by Howard L Levine (1990), 250 patients who underwent FESS 
(42 unilateral, 208 bilateral) for nasal polyposis and chronic 
inflammatory disease of the  sinuses  from  Jan  1986-1988,  were  
evaluated.  21  had concomitant resections of conchae bullosa and 41 
had septoplasties. Nasal drainage and facial pain were among the most 
common symptoms. 8.3% had minor complications and 0.7% 
experienced major complications. There were about 221 patients who 
were available for long term follow up of 12 to 42 months (mean=17 
months) with series success rate for polyposis was 89.7%  and for 
chronic sinusitis was 80.2% 11. 
Brain L Mathew et al (1991) studied pre-operative complaints, 
clinical findings, CT - extent of disease and surgical outcomes, 
retrospectively in 155 persons, with a median study period of 1 year. 
Nasal obstruction was the commonest symptom (n=146-96%) followed 
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by postnasal drip (n=143,92%) & facial pain/headache (n=139-90%). 
Indications for FESS were persistence of symptoms despite aggressive 
medical therapy and radiologic evidence of a significant sinus 
abnormality. Hemorrhage occurred postoperatively in 2 patients (1.3%) 
& 17 patients (12.7%) required additional endoscopic surgery. Overall, 
140 patients (91%) believed that surgery was beneficial. Patients with 
facial pain preoperatively  showed  greatest  improvement.  Total  
opacification  of  maxillary sinuses  was  not  a  predictor  of  outcome,  
but  opacification  of  sphenoid  sinus correlated with a poorer 
outcome12. 
Nayak et al (1991) studied a group of 78 patients (30 unilateral 
disease & 48 bilateral disease) between 12 to 57 yrs with chronic 
sinusitis over a period of 16 months with various nasal complaints, the 
commonest complaint being nasal discharge (27 unilateral, 34 
bilateral), followed by headache (26 unilateral, 33 bilateral) and nasal 
obstruction (21 unilateral, 38 bilateral), with a range of duration of 
symptoms being 3 months to 30 yrs. All except 3 of these patients 
were subjected to FESS under local anesthesia. 47 of these patients 
had total relief, 12 had partial relief and 7 had no relief. 12 patients were 
lost for follow up. 
6 patients had recurrence and were taken up for a second 
procedure. There were no complications reported 13, 14. 
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A retrospective study of 129 patients was done between July 
1991-Dec 1993 (30 months) with CRS refractory to medical treatment 
by Nasser A Fageeh et al. They were treated with FESS. The 
commonest complaint being nasal obstruction (76%), followed by 
headache (74.4%), anosmia (56.5%), & facial pressure/pain (50 %). 
Postoperatively, patients were followed up for at least 6 months. The 
most significant improvement was noticed in patients with nasal 
obstruction (60%). The least improvement occurred in patients with 
anosmia (40%). All the symptoms were assessed pre and 
postoperatively according to the severity of their symptoms by allotting 
grades. Most of the cases were done under general anaesthesia (90.5%). 
Minor complications like mild to moderate nasal bleeding, synechiae, 
and facial swelling were noted in a few patients. One major complication 
in the form of internal carotid artery rupture was observed. He was 
managed successfully with immediate nasal packing, fluid replacement 
and blood transfusion. He had no neurological sequelae. Two patients 
developed orbital haematoma. Fortunately, no loss of vision was 
encountered. The complications were comparable with other studies. 
There were 85.1 % of the patients who had a favorable opinion of the 
procedure and would recommend it to others with similar problems. It 
was also concluded in this study that preoperative CT imaging is 
essential for the diagnosis and operative planning of sinus disease. It is 
also an excellent intraoperative guide 15. 
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Jakobsen J and Svendstrup F (2000) conducted a prospective study 
on 237 consecutive patients, from 1989 to 1999, to study the effect of 
FESS in patients suffering from long standing sinusitis and /or nasal 
polyp. Nasal obstruction was the most frequent symptom (61%) 
followed by purulent nasal discharge, and other symptoms. They had 
symptoms for a period in average of 9.3 years. Among them for 86% were 
performed surgery. In them 72% ethmoids opened,54%sphenoidotomy 
performed,82% meatal antrostomy performed and for 51% frontal 
sinusotomy done. No serious complications were registered. At the end 
of 1 year follow up, 45% were satisfactory with the results and were 
symptom-free, and 44% more definitely felt good 16. 
To determine the effectiveness of FESS for CRS, a non-
randomized prospective clinical study was done by Bhattacharyya A 
(2004). 100 patients with  and 1 month. Pre operative major symptom 
marks were ranging 2.5-3.5 ans minor symptoms marks were 0.8 to 2.8 as 
per Likert’s scale and post operative decrease in both the scores occured 
for the individual symptoms (P<0.001) .Thus FESS produced significant 
improvement of all the symptoms17. 
Senior B A et al (1998) study shows a long observation period 
(average 7.8 years) of 72 patients. In them 91.6 % (n=66) improved 
post-operatively. The subject improved in terms of scoring on longer 
observation period but was statistically insignificant..13(18%) required 
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revision surgery. This study emphasised the fact that if sufficient post 
operative care given then it alleviates the need for second sitting 18. 
Retrospective analysis of data on 100 rhinosinusitis patients who 
had undergone FESS was presented by Roth Y et al (1995). High rate of 
good results (79%) and a low rate of complications (17% all minor). 
All satisfactorily comparable to those reported from other centers 19. 
A review of recent FESS literature, including 10 large series having 
a sample size of 1,713 subjects, by Terris M H and Davidson T M 
(1999) shows a 91 % improvement rate. Subjectively, 63% of patients 
reported very good result, 28% a good result and 9% an unsatisfactory 
result.12 % of the patients required revision surgery. Major  omplications 
occurred in 1.6% of the patients 20. 
CRS restricts quality of life of many of involved patients. 279 
such patients were included in a study done by Damm M et al (2002) 
from 1995-1999 assessed the effect of FESS on symptoms and nature of 
life. The nature of life was restricted by CRS in 94% of all the patients 
before surgery and ranked as severe or intolerable in 74%. The 
predominant  symptoms of CRS were nasal obstruction in 92% and 
postnasal discharge in 87%. Furthermore, patients reported 
respi ra tory t ract  in fect ion  in 68%, decreased smell  in 66%, 
cephalalgia in 64% and asthmatic complaints in 34%. After a p o s t  
s u r g i c a l  follow-up of 31.7 months, an improvement of quality of 
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life was achieved in 85%, nil change in 12%, and worsening in 3%. 
The ranking of symptoms improved from severe to mild (P<0.01). 
Mainly symptoms that improved were nasal obstruction (84%), 
headache (82%), and postnasal drip (74%) (All  P<0.01).  Hence, it  was 
decided  that the above  symptoms  improved  in  excellent explaining the 
success of FESS 21. 
Hoffmann et al (1993) conducted a study which was outcome 
based and longitudinal study of sinus symptoms prevalence in 31 
patients treated with endoscopic sinus surgery for chronic sinusitis. 
Patients completed structured data collection forms to quantify the 
prevalence of commonly experienced sinus-related symptoms during an 
eight-week period preoperatively and six months post operatively. 
Significant improvement in nasal symptoms prevalence (post-surgery 
versus pre-surgery) were noted for cephalalgia, nasal obs truct ion , 
nasal congestion, recurrent infection. In addition, the proportion of 
subjects said their health as "better" compared to a year previously 
thei r  percentage of  improvement  of  symptoms increased from 
27% pre-operatively to 58% six months post operatively. These 
statistical data in terms of quantification give a clear cut  evidence  of  
improvement  of  symptoms which affected their day to day activities 
thus once again proving that Functional Endoscopic sinus surgery  is the 
best method in improving the nature of  life  for individuals suffering 
from  chronic rhinosinusitis 22. 
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Iro H et al (2004) assessed, in a retrospective study, the 
medium-term clinical outcome of FESS in 208 patients with CRS with a 
mean follow up of 3.1 years. A questionnaire focusing on nasal 
obstruction, rhinorrhea, nasal dryness/crusting, sneezing, headache, 
smell, numbness in cheeks and lips, ear fullness, epiphora and sore 
throat was used. In addition, subjective influence of sinus surgery on 
asthma, bronchitis and allergic disease was evaluated. Overall success 
was reported by 92% of all patients. 41% of all patients with complete 
ethmoidectomy and 32% of all patients with pansinus surgery described 
complete resolution of complaints. No difference in clinical success 
rates was noted when comparing primary surgery or revision. A 
favourable effect was also reported for asthma, bronchitis and allergic 
disease. It was concluded in the study that there was improvement for 
nasal symptoms and coexisting complaints after FESS. The value of 
FESS is underlined for treatment of patients with CRS 23. 
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ANATOMY  - LATERAL WALL  AND PARA  NASAL 
SINUSES 
A. DEVELOPMENTAL ANATOMY 
I)  LATERAL WALL OF THE NOSE 
The relationships of structures contributing to lateral wall of nose 
are complicated and understood if embryology is considered.  
Zukerkandl and others showed that ethmoid turbinate originate from 
ridges in the lateral wall of the fetus in the 9th to 10th weeks. Six major 
furrows (S1-S6) develop that may be reduced by fusion to 3 to 4. These 
furrows are separated by ridges, that have an  anterior portion (ramous 
ascenders) and posterior, inferior and more horizontal portion (ramous 
descendents) (fig 1). 
The complex ethmoid  labyrinth of the adults are reduced into a 
series of lamellae depending on embryologic precursors. Their 
significance are appreciated during the endoscopic sinus surgery as they 
are encountered from anterior to posterior.   The  first  basal  lamella  is 
uncinate process, the second one is ethmoid bulla, the third o n e  is the 
base of middle turbinate and the fourth o n e  is the base of the superior 
concha. Maxillo  turbinals  (MT) form the inferior turbinate which is an 
individual bone. 
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Table  - 1 :  Development of the lateral wall of the nose 
FURROWS STRUCTURES FORMED 
First furrow Frontal recess, Ethmoidal 
infundibulum, Middle meatus.  
Second Furrow Superior meatus 
Third furrow Supreme meatus 
Fourth, fifth & sixth furrow Disappears 
 
RIDGES STRCTURES FORMED 
First ridge Agger nasi, Uncinate. 
Second ridge Middle concha 
Third ridge Superior concha 
Fourth & Fifth ridges Supreme concha 
 
1) PARANASAL SINUSES (fig 2) 
MAXILLARY SINUS-ANTRUM OF  HIGHMORE  
Maxillary sinus  first appears at 7-10 weeks as shallow grooves 
which expands from the ethmoidal infundibulum (primitive) into the 
main maxillary mass bulk. At birth the dimensions are  7x 4x 4 mm 
pyramid shaped cavity filled with fluid. The Sinus grows in a  biphasic 
manner  with growth during 0-3 yrs and 7-12 yrs at the rate of about 
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2mm vertically and 3mm anteroposteriorly (fig 2). During the second 
stage,when permanent teeth takes  their place  pneumatization spreads 
inferiorly.  Either pneumatisation is so extensive that the root of tooth can 
be separated from the sinus by only a thin mucosa intervening. In old age  
secondary to tooth loss ,alveolus  gets resorbed and secondary to it the 
sinus gets enlarged. 
ETHMOID SINUS 
The ethmoidal cells are found  as furrows in the lateral wall from 
the 3rd month of intrauterine life. A few cells filled with fluid are 
present at birth. Anterior ethmoidal cells are the one which develop 
initially  followed by posterior group. The growth of cells take place at 
the age of 12 years. Radiologically not seen till 1 year of age. The 
pneumatisation expands and correspondingly septa thin out as the child 
grows. Ethmoidal cells  can be found above the orbit (supra orbital 
15%), lateral to sphenoids (Onodi cells 10%), into the superior wall of 
maxillary sinus (Haller cells 10%) and in front into the floor of the 
frontal sinus. These cells can cause obstruction of the normal sinus 
drainage. These variations in the normal anatomy of the sinuses 
emphasise the importance of pre operative imaging in individual patients. 
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FRONTAL SINUS 
Embryologically it corresponds to anterior ethmoidal air cells and is 
the most variable sinus in terms of shape. A small frontal recess is 
recognized from 3rd month of intrauterine life, but upward expansion 
rarely occurs before birth till the  membranous frontal bone ossification 
starts  around 2 years of age . Between the age of 4 to 7 medial and 
upward expansion occurs and by 12 years the development of frontal sinus 
is complete. This sinus is the last to complete its development  and takes 
place till early adolescense. 
SPHENOID SINUS 
Sphenoid sinus starts developing around 3rd month of intrauterine 
life as an evagination from the sphenoethmoidal recess represents a 
fluid filled small cavity, 2x2x1.5mm at birth; and its full size reached  in 
adolescence and may further expand in old age. The rate of 
peumatisation is 0.25mm per year from the age of 4 yrs but this is 
inconstant. 
A) MACROSCOPIC ANATOMY 
I. NOSE-LATERAL WALL  
The bony elevations in the side walls  of  the nasal 
cavity are termed as upper,  middle and lower turbinates and 
spaces inferior and lateral to these turbinates are the meatii named 
accordingly . 
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INFERIOR TURBINATE 
Its surface is irregular and vascular channels groove it and 
mucoperiosteum is firmly attached to it.  Its process which goes towards 
the maxilla articulates with the lower border of maxillary sinus ostium. 
In addition it joins with the lacrimal, ethmoid and palatine bones 
completing the inner wall of the duct that connects the nasal cavity with 
the lacrimal sac. The turbinate submucosally has numerous cavernous 
plexus with enormous sinusoids and the autonomic nervous system 
controls them. They contribute maximally to nasal resistance 
INFERIOR MEATUS 
Part of lateral nasal wall that is inferolateral to the inferior turbinate. 
Its extent is to the entire anteroposterior dimension of the cavity of the 
nose. The height is maximum at the junction of anterior and middle third . 
NASOLACRIMAL DUCT 
This duct drains the lacrimal sac with extension from the 
lacrimal fossa in the orbit down behind the maxillary vertical buttress 
and f i na l l y  t e r mina t es  in the front portion of the inferior meatus. 
The opening is covered by a small fold of mucosa called plica 
lacrimalis [Valve of Hausner]. The duct on an average lies  4 to 9 mm 
anterior to ostium 26. 
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MIDDLE TURBINATE 
It forms part of the ethmoid bone. The antero-superior portion of 
middle turbinate is adjacent to crista ethmoidalis of maxilla, which 
forms a bulge known as agger nasi. The posterior end attaches to the 
ethmoidal crista of the perpendicular late of the palate. The intermediate 
portion depending on it attachment is divisible into three portions , the 
front portion is vertical and oriented in sagittal plane and inserted  
directly to the base of skull at the outer edge of the cribriform plate. The  
central third attaches to  lamina papyracea by its ground lamella, where 
it runs in an  frontal plane. The  posterior third, oriented in a axial 
plane attaches to the papery thin partition or lamina papyracea 
or medial wall of the maxillary sinus by means of ground 
lamella, and forms posterior part of roof of  middle meatus. Posterior 
ethmoidal cells can indent the ground lamella anteriorly, and anterior 
ethmoid cells or retrobullar recess can indent the ground lamella 
posteriorly 26, 27. 
AGGER NASI 
It is a prominence on the side wall just in front of  middle 
turbinate insertion. Frequently pneumatized by an agger nasi cell that 
arises from the upper aspect of the infundibulum. An large agger nasi 
cell may cause  frontal recess to become narrow  and may hinder in  
frontal sinus drainage. 
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MIDDLE MEATUS 
Part of the lateral wall of the nose lying inferolateral to the middle 
concha. It receives drainage from anterior group of sinuses which are  
frontal sinus, maxillary sinus and  the anterior ethmoidal cells.  
UNCINATE PROCESS [latin: uncinatus-hook shaped] 
It is a sickle shaped structure measuring about 3-4 mm wide, 1.5 
–2 cm long entirely sagitally oriented. It is attached in front to the back 
edge of the lacrimal bone and lower to the upper edge of the lower 
turbinate. It has a back free margin, bordering the hiatus semilunaris. 
Superiorly, it may attach to lamina papyracea, superior wall of the 
ethmoid or middle turbinate 25, 27. 
BULLA ETHMOIDALIS 
Its a prominent and constant feature in the meatus thats 
inferolateral to  the middle turbinate, containing the  anterior ethmoidal 
cells which is the largest. It  variable in size and its pneumatisation may 
be complete (torus lateralis) or partial. Backwards the bulla may merge 
with the lamina basilaris or may have a space between them called sinus 
lateralis / retrobulbar recess, which drains medially through the hiatus 
semilunaris posterioris. Upwards it may reach the superior wall of the 
ethmoids forming the posterior boundary of frontal recess. Suprabulbar 
recess develops between the skull base and superior surface of the bulla 
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if the bulla doesnt reach the skull base. Lateral boundary of the bulla is 
formed by the thin papery bone between labyrinth and orbit 25, 26, 27. 
HIATUS SEMILUNARIS (fig 4) 
It is a two dimensional space sandwiched between the posterior 
border of the uncinate process and anterior face of the ethmoidal bulla27. 
This is also referred to as hiatus semilunaris anterioris. The ethmoid 
infundibulum is reached through this. 
ETHMOID INFUNDIBULUM (fig 4) 
It is a three dimensional space connecting the maxillary sinus 
ostium through hiatus semilunaris to the middle meatus. Infundibulum 
may communicate in front and i n  upp er  a spec t  to the frontal recess 
in about 14% of the cases. But in most situations, the infundibulum ends 
blindly into a recess formed by the upper attachment of uncinate  to  the  
lamina  papyracea.  This  is k n o w n  as recessus terminalis. In this case 
the frontal sinus drainage is between middle turbinate and uncinate. The 
boundaries of infundibulum are as follows Medially- the uncinate and 
hiatus semilunaris through which it communicates with the middle 
meatus Laterally- lamina papyraceae Anteriorly - acute angle formed by 
attachment of uncinate to the lamina papyraceae Posteriorly - the anterior 
face of bulla ethmoidalis Inferiorly - the process from the  inferior 
turbinate articulating with the maxilla  Superiorly- depends on superior 
attachment the uncinate. 
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OSTEOMEATAL UNIT  (fig 5) 
Osteomeatal unit is a functional rather than an anatomic 
nomanclature, which was  coined by Naumann [1965] in discussing the 
pathophysiology of sinusitis. This does not refer to a discrete anatomic 
structure, but rather to several middle meatal structures collectively, 
namely the uncinate process, ethmoid infundibulum, and ostia of the 
anterior ethmoid cells, maxillary sinus and frontal sinus. 
MAXILLARY SINUS OSTIUM 
It  is located at the upper aspect of its nasal wall of the maxillary 
bone. Its situation corresponds roughly to ethmoid infundibulum in its 
posterior half or just behind lower third of the uncinate. Compared to the 
bony defect the ostium is much smaller, due to articulation with the 
surrounding bones. In a  disarticulated bone the medial wall of maxillary 
bone has a large ostium but in articulated bone this ostium is limited by 
articulations from nearby bones such as  Inferiorly- maxillary process of 
inferior turbinate  Anteriorosuperiorly- part of lacrimal bone Posteriorly- 
perpendicular plate of palatine bone  Superiorly- Bulla and ethmoidal 
labyrinth . 
NASAL FONTANELLES 
Just posterior to maxillary sinus ostium and inferior to lamina 
papyracea is the membranous wall called nasal fontanelles that 
 25 
separate the maxillary sinus from the nasal cavity. They lie 
immediately anterior (anterior fontanelle) and posterior (posterior 
fontanelle) to the inferior aspect of the uncinate process. The posterior 
fontanelle is much larger and more distinct than its anterior counterpart. 
The fontanelles, especially the posterior may be perforated creating 
accessory ostia (20-25%). These accessory ostia are always indicative of 
previous sinus infection. The antrochaoanal polyp or the killian’s polyp 
always arises from the accessory ostia situated in   the  posterior 
fontanelle. 
FRONTAL RECESS  (fig 6) 
This is found in upper and front portion  of  the middle meatus. 
The natural ostium of frontal sinus presents as an hourglass narrowing 
opening directly into the recess.  
The boundaries of frontal recess are  
Superiorly- skull base  
Medially - middle turbinate 
Laterally- lamina papyraceae 
Inferiorly- depends on the superior attachment of the uncinate 
process  
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SUPERIOR TURBINATE 
It is a part of the ethmoid bone and is the smallest turbinate, 
situated about : 
1.25 cms inferior to the  cribriform plate. SUPERIOR MEATUS 
It is the space lying inferolateral to the upper concha. Posterior 
group of  ethmoids drain in this area. 
SUPREME TURBINATE 
This may be found above the superior meatus in 60 to 70% of the 
subjects, sometimes posterior ethmoids may drain in this area also. 
SPHENOETHMOIDAL RECESS 
It is the space posterior and superior to the highest concha. The 
posterior ethmoidal cells and the sphenoid usually drain in this region. 
ANATOMIC VARIATIONS 
CONCHA BULLOSA (Fig 7) 
This is a pneumatisation of   middle turbinate  by the ethmoidal air 
cells. When present the concha bullosa may obstruct the infundibulum 
and cause narrowing of the osteomeatal complex . 
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PARADOXICAL MIDDLE TURBINATE 
This is middle turbinate with its convexity facing  laterally as 
opposed to the usual medial convexity. A paradoxical middle turbinate 
may cause narrowing of osteomeatal complex. 
UNCINATE  
This is either medially or laterally rotated. When medially 
rotated, the uncinate process may be in contact with the middle 
turbinate, narrowing the middle meatus. The surgeon should be careful 
while incising the laterally rotated uncinate process to prevent entry 
into the orbit. At times, the uncinate process may be pneumatized 
causing narrowing of the infundibulum. 
BULLA ETHMOIDALIS 
Over pneumatization of bulla ethmoidalis produces extensive 
contact areas with the middle turbinate causing obstruction in the 
mucociliary pathway. 
AGGER NASI 
When well pneumatized the agger nasi cells may hinder the  
drainage of the frontal recess and must be cleared. 
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HALLER CELLS 
These cells develop along the floor of the orbit and may 
constrict the posterior aspect of the ethmoid infundibulum. 
ONODI CELLS 
The posterior ethmoid cells may extend in a outward or 
backward fashion beyond the anterior wall of the sphenoid . These 
posterolateral cells are called Onodi cells. Its importance is while 
dissection in this plane it is possible to penetrate the skull base or  injure 
the optic nerve. 
LATERAL  WALL -ARTERIAL SUPPLY 
The antero superior quadrant is supplied main ly by the anterior 
ethmoidal artery in addition to  posterior ethmoidal and facial artery.  
Anteroinferior quadrant is supplied   by   branches   from   the   facial   
and   greater   palatine   artery.   The posterosuperior  quadrant  is   by  
the  sphenopalatine  artery  and  the posteroinferior quadrant is  by the 
greater palatine branches. 
VENOUS DRAINAGE 
The veins form a plexus, form three groups, the anterior group 
into facial vein, the middle group into the ptrygoid plexus and  the  
posterior group into the pharyngeal plexus. 
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NERVE SUPPLY 
GENERAL SENSATION : 
The anterosuperior quadrant is supplied by the anterior ethmoidal 
nerve, anteroinferior quadrant by the anterior superior alveolar nerve, 
posterosuperior quadrant by the posterior superior lateral nasal branches 
of the sphenopalatine ganglion, and posteroinferior quadrant is supplied 
by the anterior palatine branches o f  sphenopalatine  ganglion. 
SPECIAL SENSORY: 
Olfactory nerves supply the area above superior concha and 
corresponding part of the septum. 
LYMPHATIC DRAINAGE 
Anteriorly lateral wall  drains into the submandibular lymph node, 
posteriorly directly to upper deep cervical or indirectly through the 
retropharyngeal group of nodes. 
I. PARANASAL SINUSES 
MAXILLARY SINUS 
It  is pyramid shaped, which has a volume of 15 ml. Its 
dimensions are 34x 33x 23 mm. Its like a pyramid with its base directed 
towards lateral wall of nose and apex pointing towards zygoma. The 
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anterior wall has a foramen through which the infra orbital nerve comes 
out and ends by supplying the cheek. The medial wall is the lateral wall of 
the nasal cavity and the superior wall forms the floor of the orbit and the 
posterior wall forms  anterior wall of the pterygopalatine fossa .  Initially 
the floor is above the nasal cavity. At age 9 yrs it is at the level of the 
nasal floor. The depth of floor of the sinus increases as the 
pneumatisation increases. 
ARTERIAL   SUPPLY 
Branches from infraorbital, sphenopalatine, greater palatine and 
superior alveolar  Arteries. 
VENOUS DRAINAGE 
Drains into facial vein in front and into maxillary vein posteriorly. 
NERVE   SUPPLY 
By greater palatine and infra orbital nerve branches 
ETHMOID SINUS 
Anterior and posterior ethmoid cells have a total volume of about 
15 ml. Its dimensions are 33x 27x 14 mm. They are shaped like a 
pyramid with the widest base directed  posteriorly towards the sphenoid 
and apex d i r ec t ed  anteriorly. They are divided into numerous cells by 
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thin septations. The roof of the ethmoid slopes inferomedially and is thin 
medially than laterally (by a factor of 10). Medially, the roof is formed 
by the lamella lateralis of the cribriform plate, which is variable in 
vertical height with respect to the olfactory fossa depth .  KEROS’S 
classification is based on  olfactory fossa depth  (fig 8) 
1 to 3 mm deep – Type I 4 to 7 mm deep – Type II 
8 to 16 mm deep – Type III 
Type III is said to carry the greatest risk of inadvertent anterior 
skull base injury. 
The posterior ethmoidal cells border the sphenoid sinus, and  
lamina papyracea forms the lateral wall. 
ARTERIAL  SUPPLY 
It is supplied by the sphenopalatine and ophthalmic arteries. 
VENOUS DRAINAGE 
Go along with the corresponding arterial tree.  
NERVE SUPPLY 
Upper part by the branches of ophthalmic division and lower part 
by the maxillary  division of the trigeminal nerve. 
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ETHMOIDAL ARTERIES AND VEINS  (fig 9) 
The ethmoidal arteries are branches from the ophthalmic artery, a 
branch of the internal carotid. The anterior ethmoidal artery passes 
through the anterior ethmoidal artery canal in the medial orbital wall, 
usually at the junction of the frontal bone and lamina papyracea, 
traverses the roof of the ethmoid, passes through the  attachment of 
the middle turbinate in its vertical plane where it abuts  base of the skull 
and reaches the superior surface of the cribriform plate where it gives a 
meningeal branch. The artery then passes down to supply the upper nasal 
septum and lateral wall of the nose, sending a terminal branch to the  
nasal  dorsum between the nasal bones and upper nasal cartilages. The 
artery crosses the roof of the ethmoid immediately behind the frontal 
recess and may run in a dehiscent canal or in a mucosal fold. The place 
the artery enters the anterior fossa medially may be readily breached. 
The anterior ethmoidal artery may show variations as  absent 
unilaterally in 14%, bilaterally absent in 2%, or multiple in 30%. In its 
absence its posterior counterpart replaces it. The smaller posterior 
ethmoidal artery runs through the canal in the inner wall of orbit to 
supply the posterior ethmoid cells, and gives a meningeal branch, and 
terminates in the nasal branches anastomosing with the sphenopalatine 
artery. The ethmoidal veins drain into the ophthalmic veins following 
the arteries. 
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FRONTAL SINUS 
This sinus has a volume of approximately 6-7 ml. It dimensions 
are 28x 24x 20 mm. Anatomically the frontal sinus  is funnel shaped. 
Both  the  frontal sinuses have their natural  ost ia  at the most 
dependent portion of the sinus (posteromedial). Posterior wall is thinner 
compared to the anterior wall . 
ARTERIAL   SUPPLY 
Supratrochlear and supraorbital branches of ophthalmic arteries. 
VENOUS  DRAINAGE By ophthalmic vein to cavernous sinus . 
NERVE SUPPLY 
By the supra orbital and supra trochlear nerve. 
SPHENOID SINUS 
It  has  a  volume  of   7.5  ml  and  dimension  are  23x  20x  
17mm. Depending on its degree of pneumatisation it is  classified into 
three types.  
CONCHAL TYPE: The pneumatization is limited to the area of 
the attachment of the superior concha. This type of sphenoid is a 
contraindication for pituitary surgery.   
 
 34 
PRE-SELLAR TYPE :  The pneumatization does not extend 
beyond a perpendicular plate of tuberculum sella 
POST-SELLAR TYPE: This is the most common and 
pneumatisation extends posteriorly along the entire anteroposterior length 
of the body of the sphenoid upto the clivus. 
The anterior and superior walls are of variable thickness and the 
roof is the thinnest . The other walls are thicker. Two projections that are 
visualised in the lateral wall within the sphenoid sinus are the optic nerve 
above and the internal carotid artery below. In about 25% of the cases 
the carotid artery may be totally or in part dehiscent. Optic nerve is 
dehiscent in 6 % of the cases. The front surface of the sphenoid sinus is 
approximately 7 cms posterior to  anterior nasal spine making an angle 
of 30 degrees to the floor. In the roof of the sphenoidal sinus presents 
a convex bulge produced by the pituitary fossa. 
ARTERIAL SUPPLY 
Sphenopalatine and the posterior ethmoidal arteries supply the 
sphenoid sinus. VENOUS  DRAINAGE 
This is by the maxillary vein and the pterygoid venous plexus 
into the jugular veins. 
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NERVE SUPPLY 
Are   by   the   nasociliary   N,   posterior   ethmoidal   N   and   a   
branch   of   the sphenopalatine nerve. 
A) MICROSCOPIC ANATOMY 
The lining epithelium of the sinuses is pseudostratified ciliated 
columnar epithelium or the respiratory epithelium, which is in continuity 
with the mucosa of the nasal cavities.  The four cells and their functions 
are first the ciliated cells with their (9+2) arrangement of microtubule with 
dynein arms in each cilia clear secretions at a rate of  9mm/min and beat 
rate is 70-80 times/min,there are 50-200 cilia/cell. The cells which do not 
have cilia have microvilli which increase the surface area and aids in 
humidification. The basal cells act as reserve cells and helps in 
regeneration of cells when damaged. The goblet cells secrete glycoprotein 
which increases the viscosity of the nasal secretions. They are supplied 
by the p a r a sympathetic and sympathetic nervous system. 
Parasympathetic are secretomotor and their stimulation induces thicker 
mucous and sympathetic stimulation induces watery  secretion.  A thin 
basement membrane, lamina propria and periosteum support the 
epithelium. The secretory glands extend into the lamina propria. Highest  
density of goblet cells are found in maxillary sinus . The openings of the 
sinuses contain increased number of submucosal serous and mucinous 
glands 25. 
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PHYSIOLOGY - OF  PARANASAL  SINUSES 
The direction  of beat of the ciliated cells are in a specified manner. 
A specific pattern of mucus flow results. The mucociliary transport of  
mucous occurs in a genetically predetermined fashion. The transport is 
always directed towards the natural ostia and a dependent opening like 
intranasal antrostomy doesnt help in drainage.  Mucosa contact between 
two adjacent areas such as when it occurs in case of osteomeatal unit 
narrowing  arrests the mucociliary transport leading to stagnation and 
subsequent infection. Restoration of the mucociliary transport mechanism 
leads to clearance of the disease and this forms the basis of  Functional 
endoscopic sinus surgery.  
Mucociliary clearance in the frontal sinuses advances along the 
medial wall, and then moves laterally along the roof,then to lateral wall  
and medially along the floor towards the ostia. It recirculates several 
times within the sinus before it is cleared off the sinus. In the maxillary 
sinus, mucociliary movement is towards the ostium. It begins at the 
floor and radiates along the wall of the sinus superiorly. Even after 
creation of antral windows by intranasal antrostomy mucociliary 
movements persists in its upward direction towards the natural ostium. 
The frontal and maxillary sinuses are dependent sinuses, subordinate to 
their prechambers in the ethmoid and lateral nasal wall 29. 
 
 37 
PATHOPHYSIOLOGY OF SINUS INFECTION 
Drainage and ventilation of the larger sinuses play a vital role in 
the maintenance of their normal functions. The ventilation and drainage 
of the maxillary and frontal sinuses pass through very narrow and 
complicated clefts before they reach the middle meatus. These clefts 
are the ethmoidal infundibulum and frontal recess respectively, are parts 
of the anterior ethmoids.  The  larger sinuses therefore depend on the 
health and proper functioning of these prechambers. Those disorders 
which produces stenosis of these very narrow important  areas may 
result in the contact of the mucosal surfaces with mucus 
retention.Naumanns concept says  a vicious cycle is initiated by the 
infundibular blockage. This blockage results in stagnation of secretions 
and predisposing to infections which attracts inflammation which results 
in further edema and destruction of  the respiratory epithelium and  
impaired mucociliary activity aggravating further stagnation and infection. 
Thus the cycle continues. 
Though  the symptoms of infection are attributed to  these larger 
sinuses, the underlying cause is generally not to be found in the larger 
sinuses themselves, but in the clefts of the anterior ethmoid in the lateral 
nasal wall. Messerklinger in his study observed that limited resection of 
the disease with the clearing the vital areas of the anterior ethmoid, re-
establishes the a e r a t i o n  a n d  c l e a r a n c e  via the natural 
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pathways. Even massive mucosal diseases in the  frontal and maxillary 
sinuses usually heal without much intervention in these sinuses. 
CHRONIC RHINOSINUSITIS 
Chronic inflammation of mucosa of nasal cavity one or more 
sinuses is known as chronic  rhinosinusitis. Depending upon the duration 
of symptoms sinusitis mayy be classified as acute(7 days to 4 weeks),sub 
acute(4 weeks to 12 weeks) or chronic( >12 weeks). Statistics   suggest 
that CRS is more commoner  than arthritis and hypertension in general 
population. CRS impai rs  the  quality of life of an individual worser, 
than chronic non communicable diseases such as diabetes mellitus and 
congestive heart failure. Furthermore, Chronic sinusitis causes significant 
physical symptoms in addition to affecting  the functional and emotional 
aspects of an individual. 
A better understanding of the etiopathogenesis of CRS plays a 
vital role in developing effective treatment. A recent concept of “one 
airway disease”, as the upper/lower respiratory tract, middle ear cleft are 
related to one and other. Hence treatment of the upper airway 
automatically leads to improvement of lung function.. Patients with 
sinonasal polyp also suffer from bronchial asthma and aspirin 
hypersensitivity - Samter’s triad. By definition CRS is a chronic 
inflammation of the mucosal lining of the nose and the paranasal sinuses 
for a period of more than 12 weeks31,32. Histopathologically, CRS is 
divided into two broad categories: 
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1. Polypoidal mucosal changes with eosinophilia, representing 
more severe damage. 
2. Submucosal serous gland hyperplasia. 
The use of HPE in the diagnosis of CRS is not feasible 30. 
Tissue sampling is invasive not available to all physicians involved in 
CRS diagnosis and treatment. 
Table – 2 : Factors associated with CRS 
SYSTEMIC 
HOST FACTORS 
TOPICAL HOST 
FACTORS 
ENVIRONMENTEL 
FACTORS 
Allergy 
Immune deficiency 
Genetic 
Congenital 
Mucociliary 
malfunction 
Endocrine 
Neuromechanism 
Anatomical 
Concha bullosa 
Enlarged ethmoidal 
bulla 
Everted uncinate 
process 
Paradoxical middle 
Turbinate 
Agger nasi cells Haller 
cells 
Deviated nasal septum 
Neoplastic 
Acquired mucociliary 
dysfunction 
Medications Trauma 
Surgery 
Micro-organisms 
(bacteria, fungus, 
viruses) 
 
Irritant chemicals, 
pollutants, smoke 
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Pathophysiology of CRS 
1) Allergies and CRS 
T here is an increase in association of AR in patients with 
CRS. Mechanism by which AR can cause CRS include sinonasal 
mucosal edema produced by allergic inflammatory mediators like 
histamine, cytokines and other allergy mediators, causing obstruction of 
the ostium leading to infection by bacteria which proves the Naumann 
concept. Hence allergic patients having CRS do not respond much to 
medical management. 
2) Bacteria and CRS 
Their role may be direct by initiating inflammation and edema thus 
obstruction and stagnation of secretions or indirect as secondary to 
stagnation of secretions due to edema by non infective cause. Bacteria 
found in association with CRS are peptostreptococus, propioniibacterium 
spp,   prevotella,   streptococcal   variants,   cornybacterium   spp,   
Haemophilus influenzae, pseudomonas spp, enterobacter spp 31. 
3) Fungi in CRS 
Two types are recognised one is the disease due to actual fungal 
colonisation  due to secondary infection and in these situations treatment 
aimed at eradication of the fungus. And in the second scenario actual 
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fungal elements are little but the  inflammatory chain of reactions to the 
fungus are debilitating and hence treatment aimed at supressing the 
inflammation31. 
Clinical features of CRS 
Diagnosis of CRS requires the presence of either two major 
factors, or one major and two minor factors 30. The signs and 
symptoms must persist for at least 12 consecutive weeks to qualify for 
CRS. 
Table 3 : Sinus Symptoms 
Major criteria Minor criteria 
Facial pressure/pain Nasal 
obstruction Purulent nasal 
discharge Post nasal drip 
Hyposmia/anosmia Fever (acute) 
Headache 
Fever (non-acute) Halitosis 
Dental pain Cough 
Ear pain Ear fullness 
 
Clinical examination 
External findings: swelling and erythema of the maxillary, 
ocular and frontal areas. 
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Anterior nasal examination: hyperemia, edema, crusts, purulence, 
polyps, and changes in appearance after topical decongestion 33. 
Investigations of CRS 
Apart from the routine blood and urine examinations certain 
specific investigations are done namely nasal endoscopy, radiographs, 
CT Scan, & MRI. 
A) Diagnostic Nasal Endoscopy 
Nasal endoscopy is commonly used by otolaryngologist and can 
be helpful in the diagnosis of CRS. Nasal endoscopic findings in CRS 
may be: Narrowed osteomeatal complex/purulent discharge in sinus 
ostia, polyp . Other associated findings are blue discoloration of mucosa, 
DNS, concha bullosa, paradoxical middle turbinate, prominent 
bulla,enlarged agger nasi narrowing frontal recess,medialised uncinate 
and other physical/obstructive anomalies . 
B) Radiological  
Radiological evaluation depicts the accurate clear cut extent of the 
disease and the deranged or the normal anatomy containing or 
surrounding the disease. The information subsequently facilitates safe 
surgery with a well-defined “road map” prior to surgical intervention . 
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1) Radiographs: 
Excepting for  poor delineation of bony anatomy due to the problem 
of superimposition, antero-posterior or the Water’s view gives good view 
of the maxillary and the frontal and skull lateral view of the sphenoid 
sinus. 
2) Computed Tomography (fig 12,13):  
This is the investigation of choice as bony landmarks and other 
anatomical variations are delineated accurately like extent of 
pneumatisation of the sinuses in particular the ethmoids and low lying 
anterior skull base etc. It actually forms a roadmap prior to surgery.35,36. 
The following parameters are used while performing this evaluation: 
Patient position: Prone with chin hyperextended. Gantry angulation: 
Perpendicular to bony palate. 
Extent of examination: From  frontal sinus through sphenoid sinus. 
Slice thickness: 3 mm. Table incrementation: 3 mm Field of view: To  
include only the nasal cavity and PNS. 
Windowing:  For soft  tissue  and  air  passages-start  with  
window  width  of  +2000 and a center of –200. Potentiometers are 
adjusted for best display  of uncinate process and bulla ethmoidalis, and 
the images are recorded at this setting for the entire examination. For 
bone structures window width of +1500 and a center of +300 is used. 
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3) Magnetic Resonance Imaging: MRI is best suits for visualising  soft 
tissues alone and disadvantage is bone and air doesnt give good signal 
intensities   and assessing osteomeatal air passages and their bony 
perimeter is difficult. The signal intensities doesnt differ between those 
emitted from the inflammatory process from that due to normal mucosa 
which is in a edematous phase . 
Treatment of CRS 
Antimicrobial agents: generally used are penicillins in combination 
with beta lactamase inhibitors or third or fourth generation 
cephalosporins or aminoglycosides or fluoroquinolones depending on the 
culture sensitivity of the offending organism.  The length of therapy is at 
least 3 weeks, and may be extended up to 10 weeks. Debridement  of the 
affected sinuses  forms the mainstay of treatment for fungal sinusitis 
followed by antifungal therapy (e.g.: fluconazole)  
1) Decongestants: Decongestants are important in reducing  local 
mucosal edema and to improve ventilation and drainage of stagnated  
secretions via the sinus ostia. These alpha-adrenergic agonists may be 
administered either topically or systemically. 
 Topical decongestants: Long acting nasal preparations such as 
oxymetazoline, which can be administered twice daily, possess the 
advantage of direct application and relative freedom from systemic 
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effects (when used in normal dosage). Nasal decongestant sprays or 
drops can however have a side effect of rebound phenomenon of 
mucosal congestion when withdrawn when administered for periods 
longer than 5 to 7 days. Hence, topical decongestants are not used  in 
the long- term management of sinusitis. 
 Systemic decongestants: The most commonly used systemic 
decongestants are pseudoephedrine and phenylpropanolamine. Their 
actions are similar and both possess  the  potential  for  producing  the  
side  effects  due  to  alpha-  adrenergic stimulation: nervousness, 
insomnia, tachycardia and hypertension 39. 
 Mucolytics: One of the main symptoms of CRS is purulent 
nasal discharge and postnasal drip. To thickness of seretions o f   these 
secretions, both to aid in evacuation of sinus contents and to increase 
patient comfort, a systemic mucolytic agent is beneficial. The most 
widely used, and probably most effective, mucolytic for the treatment of 
CRS is guaifenesin. This preparation acts as an effective emetic in 
large doses, and to be effective as mucolytic, it must be administered 
in doses that are only subemetic (2400 mg of total daily dose) 39. 
 Nasal Toilet: Saline nasal sprays or irrigations can be used in 
cleansing thick nasal  and  sinus  secretions.  To  mucolytic effect of  
saline is augmented by  an alkaline, aromatic solution such as alkalol 
can be added to the saline in roughly equal parts. A variation in nasal 
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toilet is the delivery of warm saline into the nasal cavity via a powered, 
pulsing irrigating device such as Grossan nasal irrigator. This is not 
only helpful in patients with thick nasal secretions but also helpful for 
postoperative cleansing following intranasal sinus surgery. Some relief 
of facial pressure can also be acheived with the use of moist heat to the 
face and steam inhalation. 
 Corticosteroids: It is one of the agents in medical 
management. Preoperative administration of steroids is used for two 
reasons to minimize size of the polyp and to minimise the  blood 
loss. Postoperative steroid pulses are used for recurrent disease. Because 
of their adverse effects on many organ systems and their significant 
potential for undesirable side effects, systemic steroids are being largely 
supplanted by topical intranasal steroid sprays. 
 Topical steroids: The role of i n t r a nasal steroids in the 
treatment of sinusitis is to reduce mast cell dregranulation and 
subsequently stabilisation of mast cells and preventing synthesis and 
release of secondary inflammatory mediators thus treating the underlying 
inflammation thus reducing the edema of the osteomeatal complex. To 
be more effective, topical steroids must contact the mucosa in the 
desired area, which means that they will be less effective if the airway 
is obstructed by turbinate edema, severe DNS or large polyp. After 
the initiation of treatment, it is recommended that the patient be 
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followed up in 6 to 8 weeks to evaluate efficacy. Topical steroids in 
children have been shown to be safe, with no much side effect. Potential 
local side effects are nasal irritation, crusting, bleeding, and septal 
perforation. Prolonged use of nasal steroids may produce local 
candidiasis. Various steroid preparations available for topical therapy are 
beclomethasone, budesonide, fluticasone furoate or propionate and 
mometasone. 
1) Antihistamines: This group of drugs exerts a competitive 
antagonism of histamine binding to H1 receptors on the nerve endings, 
smooth muscle cells of the blood vessels, and glandular cells. They 
prevent histamine induced vasodilation and decrease vascular 
permeability and edema, decrease itching sensation,decrease secretion by 
seromucinous glands by their anti-muscuranic action. In addition, they 
also possess local anaesthetic and antiserotonin effects. Patients with 
allergic component in their etiology can be benefited with this. The 
concern with antihistamines is the excessive drying of secretion 
leading to crust formation, and drowsiness. Ge n e r a l   s ide effect of 
drowsiness can be overcome with the use of newer second-generation 
antihistamines. 
2) Some of the antihistamines used are cetrizine (10 mg OD/BD), 
terfenadine (120 mg/day), fexofenadine (120 mg), Astemizole (10 mg 
OD) .The latest among them being Azelastine and Ebastine. 
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3) Mast cell stabilisers: sodium chromoglycate  stabilizes the mast 
cells by inhibiting the calcium-dependent degranulation process and 
favoring the accumulation of c- AMP. Sodium Chromoglycate has the 
unique property of both preventing an allergic reaction and  acting on 
both the acute and late-phase reactions. Because of the effect of priming, 
it is important for patients who have CRS with an allergic component 
to use these group of drugs prior to anticipated antigen challenge, as 
well as for symptomatic relief during allergy seasons 39. 
4) Immunotherapy: This has evolved as a recent modality of 
treatment. Immunotherapy involves the administration of carefully 
determined doses of inciting allergens over a period of years to incite 
the formation of  “blocking antibodies”  which are IgG4 ,which prevent 
the IgE-allergen-mast cell interactions that produces an allergic events. 
FUNCTIONAL ENDOSCOPIC SINUS SURGERY 
Anesthesia 
The choice of anesthesia in FESS usually depends on the 
surgeon. Local anesthesia is often preferred as it is  safer and 
associated with less bleeding. Hypotensive general anesthesia has an 
advantage of  controlled ventilation, reduced bleeding and pain. The 
following are the sites of infiltration of the local anesthetic agent (2% 
lignocaine with adrenaline 1: 80,000)  uncinate process, bulla 
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ethmoidalis, and root, head and posterior end of the middle turbinate. 
In cases of nasal polyps, the polyps too are infiltrated. It is important to 
wait for 10 min after infiltration before surgery is commenced . 
Table 4: Instruments for FESS (Fig 14) 
1. Tilleys  Nasal dressing forceps 
2.  Ball probe 
3. Blakesley - straight or 45 degree upturned 
4. Stamburgers antrum punch forceps -backward cutting-right 
 and left, upward or downward  
5. Power driven microdebrider with blade- used in 
polypectomy or in turbinoplasty 
6.  Hazeks punch forceps 
7. Straight and curved suction tips 
Surgical Techniques 
The basic steps of the anterior to posterior technique as formulated 
by Messerklingler  include the following: 
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Uncinectomy/Infundibulotomy    (Fig 15) 
The middle turbinate is medialised  using a Freer’s elevator, the 
uncinate process is identified and its free margin is palpated with a ball 
probe. Incision is m a d e  in the groove between the uncinate process 
and the lacrimal crest, starting superiorly at the level of the insertion of 
the middle turbinate to just above the inferior turbinate. Using Blakesley 
forceps the uncinate process is grasped and removed with a twisting 
motion. 
Middle Meatal Antrostomy   (Fig 16) 
Once  uncinectomy  is done the maxillary sinus ostium can be 
approached. It is found in the junction of the anterior and inferior walls 
of the bulla ethmoidalis. If the ostium is incompletely seen, then it is 
widened with a  curette. Posterior fontanelle is noted for any accessory 
ostium. If present, the natural and the accessory ostia are connected 
using a backbiting forceps. Otherwise,natural ostium is cut with scissors 
and joined with the accessory ostia. 
Anterior Ethmoidectomy  (Fig 17) 
The anterior face of the ethmoidal bulla is entered with  tip of 
a straight forceps. The inferior and medial wall is removed completely 
while maintaining the posterior wall intact, the lamina papyracea 
forms the lateral boundary and skull base the superior boundary of 
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dissection. The posterior wall is most of the time fused with the ground 
lamella. 
Posterior ethmoidectomy   
These are entered through the infero-medial part of the ground 
lamella. The septations in them are removed carefully. The boundaries 
of dissection are posteriorly the anterior sphenoid wall,  lamina 
papyracea lies laterally,  the skull base lies superiorly and the superior 
turbinate medially. 
Sphenoidotomy    
After posterior ethmoidectomy, the sphenoid sinus is entered 
postero-infero- medially of the posterior ethmoidal cells  using a suction 
tip/forceps. The anterior wall of the sphenoid sinus can be ossified in 
some making it difficult to enter. Upto in  5% of the sphenoid sinuses 
may not be pneumatized. After entering the sphenoid sinus the bony 
anterior wall is gently removed with the Kerrison’s punch upto the 
level of skull base and medial orbital wall. The intersinus septum is 
later released and the sinus examined. 
Frontal Recess Surgery   
The frontal sinus opening can be visualized by dissecting 
upwards between the middle concha medially and the residual uncinate 
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the  lateral  l imi t . Agger  nasi  cells have to be completely removed. 
After identifying the frontal opening the, cells around the frontal 
recess are removed completely. The mucous membrane is preserved as 
much as possible, otherwise stenosis may occur. 
Post Operative Management 
After the first 24 hrs the nasal pack is removed and the patient may 
be discharged in a day or two. Subsequently the patient is followed up 
at regular intervals, every week for the first one month, every month 
for the next two months, and at the end of sixth months. 
Table 5 : Complications 
Peroperative Post operative 
Hemorrhage 
Entry into the orbit CSF leak 
Blindness Diplopia 
Injury to ICA Intracerebral  bleed 
Bleeding 
Synechia formation 
Subcutaneous emphysema 
Pneumocephalocele Meningitis. 
Epiphora Antrostomy closure 
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Fig1: Embryology of the lateral nasal wall. 
(S1 to S6-Furrows, ET-Ethmoturbinals, MT-Maxilloturbinals, NT-
Nasoturbinals, TO-Tubal opening) 
 
Fig2: Development of the paranasal sinuses. 
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Fig 3: Anatomy of lateral nasal wall. 
(SS-Sphenoid Sinus, PEC-Posterior ethmoid cell, SBR-Suprabullar 
recess, FS- Frontal sinus, AN-Agger nasi, EB-Ethmoid bulla, EI-Ethmoid 
infundibulum, UP- Uncinate process, MSO-Maxillary sinus ostium, IT-
Inferior turbinate, BL-Basal Lamella, MT-Middle turbinate) 
 
Fig 4: Hiatus semilunaris and Ethmoidal infundibulum. 
(SL-Sinus lateralis,EB-Ethmoid bulla, HS-Hiatus semilunaris,EI-Ethmoid 
infundibulum, UP-Uncinate process) 
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Fig 5: Osteomeatal unit (shaded area). 
 
Fig 6: Frontal recess. 
(FS- Frontal sinus, AN-Agger nasi, MT-Middle turbinate, MM-Middle 
meatus, FR-Frontal recess) 
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Fig 7: Concha bulosa (CB). 
 
 
Fig 8: Kero’s classification. 
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Fig 9: Anterior ethmoidal arteries. 
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Fig 10: Nasoendoscopic view of mucopus in middle meatus. (MP-
Mucopus, MT-Middle turbinate, NS-Nasal septum) 
 
Fig 11: Nasoendoscopic view of polyp arising from middle meatus. 
(LNW-Lateral nasal wall, P-Polyp, NS-Nasal septum) 
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Fig 12: CT Para Nasal Sinuses - bilateral ethmoidal polyposis. 
 
Fig 13: CT Para Nasal Sinuses - bilateral ethmoidal and maxillary 
sinusitis. 
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Fig 14: FESS instruments. 
 
Fig 15: Uncinectomy. 
(NS-Septum, I-Instrument, EAC-Ethmoid air cell, LNW-Lateral wall of 
nose, UP- Uncinate , MT-Middle concha) 
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Fig 16: Middle meatal antrostomy. 
(FER-Frontoethmoidal recess, EB-Ethmoid bulla, EMO-Enlarged 
maxillary ostium, MA-Maxillary antrum) 
 
Fig 17: Anterior ethmoidectomy, Posterior ethmoidectomy and 
frontal recess clearance being performed. (EC-Ethmoid cell, FS-
Frontal sinus) 
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Fig 18: Sphenoidotomy. Debri seen within the sphenoid sinus. 
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METHODOLOGY 
60 patients attending ENT Out Patient Department at 
Govt.Kilpauk medical college hospital and Govt.Royapettah hospital 
Chennai, with clinical features and investigations suggestive of CRS 
were randomly selected after applying the following inclusion and 
exclusion criteria: 
INCLUSION CRITERIA 
1) All cases of CRS, with infective etiology, with symptoms for 
at least 12 weeks. 
2) Patients refractory to medical treatment for a minimum of 6 
weeks. 
3) Patients above 20 years  and below 60 years old.  
EXCLUSION CRITERIA 
1) Patients below 20 years  and above 60 years old 
2) Gross DNS. 
3) Previous nasal surgeries. 
4) Complications of Chronic sinusitis. 
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1) Growth in the nasal cavity, benign or malignant, sinonasal 
polyposis. Subsequently all the selected candidates were 
worked up on the following pattern:  
HISTORY  
 Patients having either two major, or one major and two minor 
criteria/sinus symptoms were considered. Based on the scoring of Sino -
Nasal Outcome Test (SNOT-22) scoring the following scoring were 
considered for individual symptoms of the patient. Ten Chronic 
rhinosinusitis specific/related symptoms and two non specific or 
dependant symptoms were considered. Each symptom given the scoring 
as follows no problem(0), very mild problem(1), mild problem(2), 
moderate problem(3), severe problem (4) and problem as bad as it can 
be (5). In form of questionairre scoring was done preoperatively. Thus 
the scoring ranged from minimum of 0 to maximum of 60. 
 Any history of co-existing bronchial asthma, aspirin  sensitivity  or 
other systemic ailments like diabetes mellitus or hypertension or other co 
morbid illnesses was looked into. 
Any history of similar complaints in any of their family members 
was recorded. 
Personal habits with regard to smoking and alcohol intake were 
asked for. 
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GENERAL EXAMINATION 
* Vital parameters were recorded. 
* Systemic examination of the central nervous system, 
cardiovascular system, respiratory system and per abdominal 
examination were carried out. 
ENT EXAMINATION NOSE 
* External examination:  for  presence  of  any  nasal  deformity  
* Para Nasal Sinus tenderness. 
* Septum: for any Deviation of nasal septum. 
* Airway: Cottle’s test to assesss nasal valvular obstruction, cottol 
 wool test, cold spatula test. 
* Inferior turbinate: for hypertrophy, & condition of its mucosa. 
* Nasal Mucosa: whether pale/ boggy/congested/normal. 
* Meatii: For any mucopurulent or mucous discharge/polyps. 
* Posterior rhinoscopy: to assess the posterior extent of the nasal 
polyps when present or mucopurulent discharge. 
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ORAL CAVITY & OROPHARYNX 
* Buccal mucosa, tongue and dentition examination. 
* Anterior pillars and tonsil examination. 
* Posterior pharyngeal wall examined for evidence of postnasal 
drip or chronic granular changes. 
* Indirect Laryngoscopic examination done to detect the presence of 
any pathology of the base of tongue, vallecula, epiglottis, 
arytenoids, pyriform fossa or glottis. 
EAR 
* Post  auricular-area  and  pinna  examined  for  any  operative  scar  
or mastoid tenderness.  
* External auditory canal examined for the presence of any 
wax/ debris / discharge. 
* Tympanic  membrane  examined  and  a  note  made  of  its  
motility, colour, lustre any perforation, discharge. 
INVESTIGATIONS 
1) Routine hematological and biochemical examinations were  
carried  out. (Hb%, TLC, DLC, BT, CT. Urine-routine and 
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microscopy. Blood sugar- fasting and postprandial, BUN, 
Serum creatinine, when patient above 40 years or with 
history  of  DM or  HTN). 
2) Chest X-Ray and ECG done for all patient , or with history 
of HTN or bronchial asthma: to assess the general condition 
of the patient, and for fitness for surgery. 
3) X-Ray PNS-Water’s view to assess the condition of the 
septum, inferior turbinates and air-fluid levels, haziness or 
opacification of the sinuses. 
4) Diagnostic Nasal Endoscopy under local anesthesia to record 
the condition of nasal mucosa, septum, & inferior turbinates. 
To assess the condition of the nasopharynx and eustachian 
tube opening, to look for the presence of mucopus or polyp 
in the middle meatus/sphenoethmoidal recess/nasopharynx. 
For assessing the group of sinuses affected whether the anterior 
or posterior group depending on infratubal or supratubal stream 
of mucopus tracking down respectively. Also, any co-existing 
anatomical variations of the lateral wall of the nose were 
noted. 
5) NCCT PNS to assess the extent of disease, condition of 
OMU, degree of opacification of sinuses, bony erosion and 
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roof of the ethmoids among others assessing the level of 
anterior skull base, degree of pneumatisation of ethmoids and 
its encroachment to the surrounding bones like Haller cells, 
Onodi cells, Concha bullosa. This was considered as the 
surgical road map prior to sinus surgery. 
Once the diagnosis and extent of the disease was established, the 
patients were taken up for FESS, after a pre anesthetic evaluation. The 
surgery was done either under local or general anesthesia, depending 
on the following factors: 
1) Disease extent  
2) The condition of the subject in general, and 
3) Patient’s choice for the type of anesthesia. 
The surgical procedures were carried out by two senior surgeons, 
in operation theater under strict aseptic precautions , using the 
endoscopes and the entire set of instruments as mentioned .The surgical 
procedures were performed along the guidelines formulated by 
Messerklinger and Stammberger. The various procedures performed 
were uncinectomy, middle turbinate reduction, Middle Meatal 
Antrostomy, anterior and posterior ethmoidectomy, sphenoidotomy and 
frontal sinusotomy. The various surgical procedures performed depended 
upon the laterality and the extent of the disease. At the end of the 
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surgery, haemostasis was achieved and the nose packed with Merocel 
nasal pack only when the surgery was limited to the ground lamella. 
When the surgery extended beyond the ground lamella the nose was 
packed with medicated ribbon gauze (BIPP or Soframycin with 
betadine) in addition to the Merocel nasal pack. Post-operatively patients 
were started on appropriate antibiotics (e.g. Ampicillin/Cefotaxime), 
NSAIDS, oral decongestants and antacids. Nasal packs were removed 
24 to 48 hours after the surgery depending on the extent of surgery. 
Local decongestants and alkaline nasal douching (common salt-50 gm, 
sodium bicarbonate-25 gm and sodium biborate-25 gm in 250 ml of 
sterile water) was started. The patients were sent home on the 2
n d
 o r  
3
r d
 post-operative day with above-mentioned medications for an 
additional 5 days and asked to come back for review at the end of one 
week. 
During the postoperative follow-up, patient was asked to come 
once a week for first month and once a month for next two months 
.During each time endoscopy was done and crusts removed and 
suction clearance of the secretions done. Post operative 
questionairre regarding improvement of symptom profile was done 
3 weeks post op and later 3 months post op and  improvement in 
scoring for each symptom as mild or moderate or marked 
improvement or no improvement sepending on degree of 
downscoring for each symptom were considered. 
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Alkaline nasal douching was continued for the initial two to four 
weeks depending upon the amount of crusting seen during the follow-up 
nasalendoscopic examination. All the above results were tabulated and 
the symptoms before and after FESS compared statistically using Chi-
Square test. 
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Fig 19: FESS in progress. 
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Fig 20: Endoscopic picture of post operative healed cavity. 
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RESULTS 
Table-6. Age distribution 
Age range Number Percentage 
20-30 25 41.67 
30-40 20 33.33 
40-50 13 21.67 
50-60 2 3.34 
 
Table-7. Sex  distribution 
 
Sex Number Percentage 
Male 38 63.34 
Female 22 36.66 
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Table – 8 : Duration of Symptoms 
Duration Number of Patients Percentage 
3 months to 6 months 20 33.3 
6 months to 1 year 28 46.7 
1 year to 2 years 10 16.7 
> 2 years 2 3.3 
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Table – 9 : Anterior Rhinoscopy Findings 
Structures Number of Patients Percentage 
DNS 10 16.7 
Inferior turbinate hypertrophy 10 16.7 
Pale boggy mucosa 2 3.3 
Congested mucosa 4 6.7 
Polyps 2 3.3 
Mucopus 56 93.3 
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Table – 10 : Pre operative Diagnostic Nasal Endoscopic Findings 
Structures Number of Patients Percentage 
DNS 10 16.7 
Polyps 2 3.3 
Mucopus 58 96.7 
Paradoxical middle turbinate 8 13.3 
Bulbous Middle turbinate 14 23.3 
Accessory ostia 2 3.3 
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Table – 11 : CT Plain of the PNS 
Sinuses 
Right Left 
Normal Opacified Normal Opacified 
N % N % N % N % 
Anterior 
Ethmoids 
4 6.7 56 93.3 3 5.0 57 95.0 
Posterior 
Ethmoids 
4 6.7 56 93.3 3 5.0 57 95.0 
Maxillary 
Sinus 
2 3.3 58 96.7 4 6.7 56 93.3 
Frontal 
Sinus 
34 56.7 26 43.3 40 66.7 20 33.3 
Sphenoid 
Sinus 
46 76.7 14 23.3 50 83.3 10 16.7 
 
 78 
 
 
Table – 12 : Procedure Done 
Type of Procedure Nos. % 
Uncinectomy 60 100.0 
Middle Meatal Antrostomy 60 100.0 
Anterior Ethmoidectomy 60 100.0 
Posterior Ethmoidectomy 60 100.0 
Sphenoidotomy 20 33.3 
Frontal Recess Drainage 32 53.3 
Septal Correction 10 16.7 
Reduction of middle turbinate 
(Conchaplasty) 
14 23.3 
Out Fracturing of Middle Turbinate 8 13.3 
Polypectomy 2 3.3 
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Table - 13  percentage of improvement of nasal obstruction 
NASAL  OBSTRUCTION 
 
 
Nasal Obstruction: Pre Op 
Total 
Severe Very Severe 
N % N % N % 
Nasal 
Obstruction: 
3 month 
No Problem 28 82.4 13 50.0 41 68.3 
Very Mild 6 17.6 12 46.2 18 30.0 
Mild 0 .0 1 3.8 1 1.7 
Total 34 100.0 26 100.0 60 100.0 
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Fig 21. Percentage of improvement of Nasal Obstruction 
This symptom showed a good degree of improvement  as at the 
commencement of treatment  almost 99% of the subjects suffered from 
this symptom and at the end of 3 months after surgery  the success rate 
was 100% as nearly the same number (98.3%)had mild or no problem.  
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Table 14-percentage of improvement  of nasal  discharge 
NASAL  DISCHARGE 
 
Nasal discharge: Pre Op 
Total 
Mild Moderate Severe Very Severe 
N % N % N % N % N % 
Nasal 
discharge: 
3 month 
No 
Problem 
0 .0 5 71.4 36 75.0 2 50.0 43 71.7 
Very 
Mild 
1 100.0 2 28.6 9 18.8 1 25.0 13 21.7 
Mild 0 .0 0 .0 3 6.3 0 .0 3 5.0 
Moderat
e 
0 .0 0 .0 0 .0 1 25.0 1 1.7 
Total 1 100.0 7 100.0 48 100.0 4 100.0 60 100.0 
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Fig 22. Percentage of improvement of  Nasal Discharge 
 
The symptom of nasal discharge also paralleled the results of nasal 
block with the similar outcome after surgery  
 83 
 
 
 
Table 15:- percentage  of improvement of  rhinorrhoea 
RHINORRHOEA 
 
Rhinorrhoea: Pre Op 
Total 
No Problem Very Mild Mild Moderate Severe 
Very 
Severe 
N % N % N % N % N % N % N % 
Rhinorr
hoea: 3 
month 
No Problem 7 100.0 7 77.8 7 58.3 1 12.5 1 4.3 0 .0 23 38.3 
Very Mild 0 .0 2 22.2 4 33.3 1 12.5 1 4.3 0 .0 8 13.3 
Mild 0 .0 0 .0 1 8.3 2 25.0 9 39.1 0 .0 12 20.0 
Moderate 0 .0 0 .0 0 .0 4 50.0 12 17.4 0 .0 16 26.7 
Severe 0 .0 0 .0 0 .0 0 .0 0 .0 1 100.0 1 1.7 
Total 7 100.0 9 100.0 12 100.0 8 100.0 23 100.0 1 100.0 60 100.0 
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Fig 23. Percentage  of improvement of  Rhinorrhoea 
 
This symptom often associated with allergic rhinitis did not show 
much improvement as only there was only 26.6% increase in persons  
whose  became symptom free, and majority of them who were having 
severe  problem  pre-operatively just fell in the next category of moderate 
improvement. 
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SNEEZING 
Table 16. Percentage  of  improvement  of  sneezing 
 
Sneezing: Pre Op 
Total 
No Problem Very Mild Mild Moderate Severe Very Severe 
N % N % N % N % N % N % N % 
Sneezi
ng: 3 
month 
No 
Problem 
9 100.0 7 53.8 0 .0 1 7.7 0 .0 0 .0 17 28.3 
Very 
Mild 
0 .0 6 46.2 2 18.2 2 15.4 0 .0 0 .0 10 16.7 
Mild 0 .0 0 .0 9 81.8 6 46.2 1 9.1 0 .0 16 26.7 
Moderate 0 .0 0 .0 0 .0 4 30.8 9 81.8 1 33.3 14 23.3 
Severe 0 .0 0 .0 0 .0 0 .0 1 9.1 2 66.7 3 5.0 
Total 9 100.0 13 100.0 11 100.0 13 100.0 11 100.0 3 100.0 60 100.0 
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Fig 24. Percentage of improvement of  Sneezing 
This symptom results too paralleled with that of  rhinorrhoea. 
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POST NASAL  DRIPPING 
Table 17. Percentage  of  improvement  of  post nasal dripping 
 Post Nasal Dripping: Pre Op Total 
Mild Moderate Severe Very Severe 
N % N % N % N % N % 
Post Nasal 
Dripping: 3 
month 
No 
Problem 
2 100.0 4 100.0 14 38.9 1 5.6 21 35.0 
Very Mild 0 .0 0 .0 16 44.4 9 50.0 25 41.7 
Mild 0 .0 0 .0 1 2.8 4 22.2 5 8.3 
Moderate 0 .0 0 .0 5 13.9 4 22.2 9 15.0 
Total 2 100.0 4 100.0 36 100.0 18 100.0 60 100.0 
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Fig 25. Percentage of improvement of  Post Nasal Dripping 
This symptom showed a good improvement as majority of the 
patients  about 90% suffered pre operatively and about  85% at the end of 
the procedure  showed good relief of symptoms 
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HEADACHE 
Table 18. Percentage of improvement  of headache 
 
Headache: Pre Op  
No Problem Very Mild Mild Moderate Severe Very Severe Total 
N % N % N % N % N % N % N % 
Headac
he: 3 
month 
No 
Problem 
2 100.0 0 .0 2 100.0 4 57.1 12 31.6 3 30.0 23 38.3 
Very 
Mild 
0 .0 1 100.0 0 .0 1 14.3 10 26.3 5 50.0 17 28.3 
Mild 0 .0 0 .0 0 .0 1 14.3 5 13.1 1 10.0 7 11.7 
Moderate 0 .0 0 .0 0 .0 1 14.3 11 28.9 1 10.0 13 21.7 
Total 2 100.0 1 100.0 2 100.0 7 100.0 38 100.0 10 100.0 60 100.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 90 
 
 
 
Fig 26. Percentage Of improvement of  Headache 
This symptom did not show moderate improvement  as 80% of the 
patients suffered from severe headache preoperatively and post 
operatively it reduced to 61.7% patients still having the symptoms.    
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COUGH 
Table 19. Percentage  of  improvement  of  cough 
 
 Cough: Pre Op Total 
No Problem Very Mild Mild Moderate Severe 
N % N % N % N % N % N % 
Cough: 
3 month 
No 
Problem 
14 100.0 3 33.3 2 16.7 2 10.0 0 .0 21 35.0 
Very 
Mild 
0 .0 6 66.7 3 25.0 2 10.0 0 .0 11 18.3 
Mild 0 .0 0 .0 7 58.3 7 35.0 0 .0 14 23.3 
Moderate 0 .0 0 .0 0 .0 9 45.0 4 80.0 13 21.7 
Severe 0 .0 0 .0 0 .0 0 .0 1 20.0 1 1.7 
Total 14 100.0 9 100.0 12 100.0 20 100.0 5 100.0 60 100.0 
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Fig 27. Percentage  of improvement of  Cough 
This symptom showed poor improvement with still 65% of the 
patients having the symptoms at the end of 3 months of the procedure. 
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DECREASED  SENSATION  OF  SMELL 
Table 20. Percentage of improvement  of decreased sensation of smell 
 
Decreased sensation of smell: Pre Op 
Total 
No Problem Very Mild Mild Moderate Severe Very Severe 
N % N % N % N % N % N % N % 
Decreased 
sensation 
of smell: 
3 month 
No 
Problem 
2 100.0 3 100.0 8 100.0 16 84.2 17 68.0 1 33.3 47 78.3 
Very 
Mild 
0 .0 0 .0 0 .0 1 5.3 6 24.0 2 66.7 9 15.0 
Mild 0 .0 0 .0 0 .0 2 10.5 2 8.0 0 .0 4 6.7 
Total 2 100.0 3 100.0 8 100.0 19 100.0 25 100.0 3 100.0 60 100.0 
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Fig 28. Percentage of improvement of  Decreased senstion of smell 
This showed  good improvement with about 78.3% individuals 
disease free at the end of follow up 
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Table 21. Percentage of improvement of facial pain 
FACIAL  PAIN 
 
 
Facial Pain: Pre Op Total 
No Problem Very Mild Mild Moderate Severe Very 
Severe 
N % N % N % N % N % N % N % 
Facial 
Pain: 3 
month 
No 
Problem 
32 100.0 4 100.0 3 100.0 0 .0 0 .0 0 .0 39 65.0 
Very Mild 0 .0 0 .0 0 .0 1 16.7 1 8.3 0 .0 2 3.3 
Mild 0 .0 0 .0 0 .0 5 83.3 7 58.3 0 .0 12 20.0 
Moderate 0 .0 0 .0 0 .0 0 .0 4 33.3 3 100.0 7 11.7 
Total 32 100.0 4 100.0 3 100.0 6 100.0 12 100.0 3 100.0 60 100.0 
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Fig 29. Percentage  of improvement of  Facial pain 
This showed only a mild improvement with only 11.7% increase in 
symptom free subjects at the end of follow up. 
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Table 22. Percentage of improvement of ear discharge 
EAR  DISCHARGE 
 
Ear Discharge: Pre Op 
Total 
Mild Moderate Severe Very Severe 
N % N % N % N % N % 
Ear 
Discharge
: 3 month 
No Problem 2 100.0 5 71.4 14 40.0 4 25.0 25 41.7 
Very Mild 0 .0 1 14.3 16 45.7 9 56.3 26 43.3 
Mild 0 .0 1 14.3 5 14.3 2 12.5 8 13.3 
Moderate 0 .0 0 .0 0 .0 1 6.3 1 1.7 
Total 2 100.0 7 100.0 35 100.0 16 100.0 60 100.0 
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Fig 30. Percentage of improvement of  Ear Discharge 
This symptom showed a good improvement  in parallel with nasal 
obstruction, discharge, post nasal dripping etc as majority of the patients 
who were initially in the very severe or severe category  fell into no 
problem or mild problem. 
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FATIGUE 
Table 23. Percentage of improvement of fatigue 
 Fatigue: Pre Op Total 
No Problem Mild Moderate Severe Very 
Severe 
N % N % N % N % N % N % 
Fatigue: 3 
month 
No Problem 14 100.0 0 .0 1 8.3 1 3.1 0 .0 16 26.7 
Very Mild 0 .0 0 .0 0 .0 1 3.1 0 .0 1 1.7 
Mild 0 .0 1 100.0 10 83.3 13 40.6 0 .0 24 40.0 
Moderate 0 .0 0 .0 1 8.3 10 31.3 0 .0 11 18.3 
Severe 0 .0 0 .0 0 .0 7 21.9 1 100.0 8 13.3 
Total 14 100.0 1 100.0 12 100.0 32 100.0 1 100.0 60 100.0 
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Fig 31. Percentage of improvement of  Fatigue 
This symptom improvement was largely dependant upon  
improvement of allergic rhinosinusitis related symptoms. Only in 
proportion of patients who had improvement of  cough, sneezing, 
rhinorrhoea these non specific symptoms gained a significant 
improvement. 
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Table 24. Percentage of  improvement of  bodily pain 
BODILY  PAIN 
 
Bodily Pain: Pre Op 
Total 
No Problem Very Mild Moderate Severe 
N % N % N % N % N % 
Bodily 
Pain: 3 
month 
No Problem 49 100.0 4 100.0 0 .0 0 .0 53 88.3 
Very Mild 0 .0 0 .0 1 20.0 0 .0 1 1.7 
Mild 0 .0 0 .0 2 40.0 2 100.0 4 6.7 
Moderate 0 .0 0 .0 2 40.0 0 .0 2 3.3 
Total 49 100.0 4 100.0 5 100.0 2 100.0 60 100.0 
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Fig 32. Percentage  of improvement  of Bodily Pain 
 
This symptom improvement paralleled similar to fatigue 
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Table 25. Improvement scores of individual symptoms  from  
baseline at end of follow up 
DEGREE OF  IMPROVEMENT OF  SYMPTOMS FROM 
BASELINE 
Overall 
improveme
nt Pre Op to 
3 month 
No (0) Mild (+1) 
Moderate 
(+2) 
Good (+3) Better (+4) Best (+5) Total 
N % N % N % N % N % N % N % 
  Nasal 
Obstruction 
0 0.0 0 0.0 0 0.0 7 11.7 40 66.7 13 21.7 60 100.0 
  Nasal 
discharge 
0 0.0 0 0.0 6 10.0 7 11.7 37 61.7 10 16.7 60 100.0 
Rhinorrhoea 37 61.7 4 6.7 17 28.3 2 3.3 0 0.0 0 0.0 60 100.0 
  Sneezing 29 48.3 14 23.3 16 26.7 1 1.7 0 0.0 0 0.0 60 100.0 
  Post Nasal 
Dripping 
0 0.0 2 3.3 7 11.7 12 20.0 32 53.3 7 11.7 60 100.0 
  Headache 16 26.7 14 23.3 5 8.3 13 21.7 12 20.0 0 0.0 60 100.0 
  Cough 37 61.7 10 16.7 11 18.3 2 3.3 0 0.0 0 0.0 60 100.0 
  Decreased    
sensation of 
smell 
0 0.0 4 6.7 7 11.7 6 10.0 30 50.0 13 21.7 60 100.0 
 Facial Pain 11 18.3 17 28.3 9 15.0 14 23.3 9 15.0 0 0.0 60 100.0 
  Ear 
Discharge 
0 0.0 1 1.7 6 10.0 11 18.3 37 61.7 5 8.3 60 100.0 
  Fatigue 32 53.3 14 23.3 9 15.0 5 8.3 0 0.0 0 0.0 60 100.0 
  Bodily Pain 50 83.3 5 8.3 2 3.3 3 5.0 0 0.0 0 0.0 60 100.0 
Interpretation:-  
 The  symptoms for which the  improvement was (0) or (+1)  from 
the baseline score  were regarded as having no or mild improvement and 
improvement from (+2) or (+3)  from base line score were regarded as 
having  moderate improvement  and those   who improved (+4) or (+5) 
from the baseline score were regarded as having  marked improvement. 
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Table 26. Percentage  of  patients  having  mild/moderate/marked 
improvement with respect to individual symptoms 
IMPROVEMENT  OF INDIVIDUAL  SYMPTOMS IN A NUT  
SHELL 
Overall 
improvement Pre 
Op to 3 month 
No/Mild 
Improvement 
Moderate 
Improvement 
Marked 
Improvement 
Total 
N % N % N % N % 
Nasal Obstruction 0 0.0 7 11.7 53 88.3 60 100.0 
Nasal discharge 0 0.0 13 21.7 47 78.3 60 100.0 
Rhinorrhoea 41 68.3 19 31.7 0 0.0 60 100.0 
Sneezing 43 71.7 17 28.3 0 0.0 60 100.0 
Post Nasal 
Dripping 
0 0.0 19 31.7 41 68.3 60 100.0 
Headache 30 50.0 18 30.0 12 20.0 60 100.0 
Cough 47 78.3 13 21.7 0 0.0 60 100.0 
Decreased 
sensation of smell 
6 10.0 13 21.7 41 68.3 60 100.0 
Facial Pain 28 46.7 23 38.3 9 15.0 60 100.0 
Ear Discharge 1 1.7 17 28.3 42 70.0 60 100.0 
Fatigue 46 76.7 14 23.3 0 0.0 60 100.0 
Bodily Pain 55 91.7 5 8.3 0 0.0 60 100.0 
Interpretation:-  
The  symptoms for which the  improvement was (0) or( +1)  from 
the baseline score  were regarded as having no or mild improvement and 
improvement from (+2) or( +3)  from base line score were regarded as 
having  moderate improvement  and those   who improved (+4) or( +5) 
from the baseline score were regarded as having  marked improvement. 
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Fig 33. Percentage of  patients facing marked improvement of 
individual symptoms 
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ANALYSIS OF FINAL OUTCOME 
 We  used  McNemar’s  test  in  our  study.  
Symptoms  that  showed  MARKED  IMPROVEMENT (p<0.001)  
 1.Nasal Obstruction 
 2.Nasal Discharge 
 3.Post Nasal Dripping 
 4.Ear Discharge 
 5.Decreased sensation of smell 
Symptoms  that  showed  MODERATE IMPROVEMENT (p<0.05) 
 1.Facial Pain 
 2.Headache 
Symptoms that showed NO/MILD IMPROVEMENT (p>0.05)  
1.Cough 
2.Rhinorrhoea 
3.Sneezing 
4.Fatigue 
5.Bodily Pain 
 No / mild improvements are not  statistically significant (p > 0.05). 
SPSS version 20.0 is used to analyse the data. 
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DISCUSSION 
 
 
The symptoms that showed the marked improvement in majority of 
the subjects were nasal obstruction (88.3%), nasal discharge (78.3%), 
post nasal dripping (68.3%), ear discharge (70%), decreased sensation of 
smell (68.3%) and which showed no or mild improvement were, 
headache, cough, rhinnorrhoea, sneezing, facial pain, those symptoms  
associated with allergic rhinitis.  
 
And the non specific symptoms such as fatigue and bodily pain are 
largely dependant on the symptoms which showed not much 
improvement.  
 
So they too showed poor improvement in parallel to those poorly 
improved symptoms. In few proportion of the subjects in whom  these 
symptoms showed a moderate improvement the patients said they 
experienced marked improvement of these non specific symptoms like 
fatigue and bodily pain.  
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CONCLUSION 
 
 
To conclude, patients who visit the ENT out patient department 
diagnosed to have chronic rhinosinusitis generally present with an array 
of symptoms.  
 
Its critical to analyse as to which symptoms they give priority 
much. If their priority is directed to the symptoms which showed a 
marked improvement at the end of this study then patient can be assured 
of the good quality of life they would get after undergoing endoscopic 
sinus surgery in terms of their improvement of the ailment for which they 
sought for a surgical intervention.  
 
And similarly those patients presenting with predominant 
symptoms of allergy with chronic rhinosinusitis such as ,sneezing, 
rhinorrhoea, dry cough, headache or facial pain its better not to subject 
them for surgery taking into consideration the results of this study with 
regard to these symptoms. Thus anti allergic treatment measures should 
be the first line of management before planning for any surgical 
intervention for such patients.
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 PROFORMA 
 
Case Summary / Pre Operative Questionnaire 
 
Name  :       Age & Sex : 
  
 
Occupation :      OP No : 
                                                                                   IP  No : 
History :           
           
Contact No: 
 
S. 
No. 
Symptoms 
No 
Proble
m 
Very 
mild 
proble
m 
Mild or 
Slight 
problem 
Moderate 
problem 
Severe 
problem 
Problem as bad 
as it can be 
1. Nasal 
Obstructio
n 
0 1 2 3 4 5 
2. Nasal 
discharge 
0 1 2 3 4 5 
3. Rhinorrhoe
a 
0 1 2 3 4 5 
4. Sneezing 0 1 2 3 4 5 
5. Post Nasal 
Dripping 
0 1 2 3 4 5 
6. Headache 0 1 2 3 4 5 
7. Cough 0 1 2 3 4 5 
8. Decreased 
sensation 
of smell 
0 1 2 3 4 5 
9. Facial Pain 0 1 2 3 4 5 
10. Ear  
Discharge 
0 1 2 3 4 5 
 
Symptoms – Chronic rhinosinusitis  specific:- 
 
1. Fatigue 0 1 2 3 4 5 
2. Bodily pain 0 1 2 3 4 5 
 
Chronic rhinosinusitis  non specific:- 
 
Total Score : 0  to  60 
  
Associated factors:- 
 
1.Asthma/Allergy/Aspirin hypersensitivity 
2.Smoking 
3.Prior sinus surgery 
 
Past History:-  
1. Hypertension 
2. Diabetes Mellitus 
3. Bronchial Asthma 
4. Bleeding disorders  
 
Treatment History:-  
H/o previous surgery  
H/o medication 
 
Clinical Examination:  
 
Nose: 
 
1. Anterior Rhinoscopy 
 
2. Posterior Rhinoscopy 
 
3. Para Nasal Sinus Tenderness 
 
4. Cold Spatula Test  
 
5. Cotton  wisp  test 
 
Ear  : 
 
Throat :  
 
INVESTIGATIONS:-  
1.Diagnostic Nasal Endoscopy:-    
 
 
2.CT-Para Nasal Sinuses:- 
 
3.Routine Blood Investigations:-             
 ANALYSIS OF OUTCOME 
 
Symptoms –Chronic rhinosinusitis  specific:-                                                   
SCORES                
 
S.No. Symptoms Pre- 
operative  
Post operative (3 
weeks) 
Post operative  
(3 months) 
Inference 
1. Nasal 
Obstruction  
    
2. Nasal 
discharge                                                                    
    
3. Rhinorrhoea                                             
4. Sneezing                                                                             
5. Post Nasal 
Dripping                                       
    
6. Headache                                                           
7. Cough                                                           
8. Decreased 
sensation of 
smell 
    
9. Facial Pain     
10. Ear  Discharge     
 
Chronic rhinosinusitis  non specific:- 
 
1. Fatigue     
2. Bodily pain     
 Total Score     
 
Total Score Range: 0 to 60 
 
Overall  inference of Symptoms  for this patient:- 
 
No/mild improvement             moderate                             marked   
 
   
   
   
   
   
   
   
   
 
 PRE OPERATIVE SCORING 
  
 
 
 
 
  
  
  
 
 
 
  
